Tower House Partners LLP Catalent, Inc. Transaction History

Tower House Partners LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $951,968 - $1.49 Million	-13,156 Reduced 11.99%	96,528 $6.98 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $5.81 Million - $7.6 Million	-66,609 Reduced 37.78%	109,684 $11.8 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $9.15 Million - $12.1 Million	-97,141 Reduced 35.53%	176,293 $19.6 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $10.1 Million - $11.8 Million	-84,869 Reduced 23.69%	273,434 $35 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $6.15 Million - $8.02 Million	-56,334 Reduced 13.59%	358,303 $47.7 Million
Q2 2021 Aug 17, 2021	SELL	$100.34 - $115.69 $25,486 - $29,385	-254 Reduced 0.06%	414,637 $44.8 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $1.03 Million - $1.27 Million	-10,109 Reduced 2.38%	414,891 $43.7 Million
Q4 2020 Mar 05, 2021	SELL	$85.88 - $105.36 $6.75 Million - $8.28 Million	-78,600 Reduced 15.61%	425,000 $44.2 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $261,863 - $333,000	3,600 Added 0.72%	503,600 $43.1 Million
Q2 2020 Aug 10, 2020	SELL	$48.02 - $79.04 $16.8 Million - $27.7 Million	-350,000 Reduced 41.18%	500,000 $36.7 Million
Q1 2020 Jun 04, 2020	BUY	$36.95 - $62.95 $31.4 Million - $53.5 Million	850,000 New	850,000 $44.2 Million

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tower House Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Tower House Partners LLP with notifications on news.